Methods
SECONDARY
This prespecified secondary analysis of the ALLHAT, a multicenter, randomized, double-blind, active-controlled clinical trial, followed up with participants for up to 23 years, from February 23, 1994, to December 31, 2017. The methods and primary results of the ALLHAT and posttrial outcome results through 2006 have previously been published.